This cross sectional study is conducted among adults living with HIV receiving care at TAHOD study…
Category: Studies
An Open-label, Single Arm Study to Evaluate the Week 48 Efficacy and Safety of a Two-drug Regimen of Dolutegravir/Lamivudine (DTG/3TC) as a Fixed Dose Combination (FDC), in Antiretroviral Therapy (ART)-Naive HIV-1-infected Adolescents, ≥ 12 to < 18 Years of Age Who Weigh at Least 25 kg
This is a Phase IIIb, single-arm, open-label, multi-center assessment of DTG/3TC in approximately 30 HIV-1 infected,…
Coronavirus in HIV Evaluation of Outcomes in Resource Limited Settings
COHIVE is an observational cohort study nested within four parent open label randomised clinical trials of…
A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS‑6207 in Combination with an Optimized Background Regimen in Heavily Treatment Experienced People Living with HIV-1 Infection with Multidrug Resistance
The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207)…
Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses
The study is being done to: start ART early in those recently or acutely infected with…
Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control during an Intensively Monitored Antiretroviral Pause (IMAP)
The purpose of this study is to collect information about what happens when people pause, or…
Plan for obtaining human biological samples at non-U.S. clinical research sites for currently unspecified genetic analyses
This is a study to collect blood and saliva samples from former and current participants in…
A phase 3b, randomized, open-label study of the safety and efficacy of Dolutegravir or Efavirenz each administered with two NRTIs in HIV-1-infected antiretroviral therapy-naïve adults starting treatment for Rifampicin-sensitive tuberculosis
This is a Phase III b, randomized, open-label study describing the efficacy and safety of DTG…
Long-term cohort
This is a long-term, post study cohort of HIV-infected patients who previously participated in HIV-NAT study…
A randomized double-blind phase 2 study comparing the efficacy, safety, and tolerability of combination antivirals (Amantadine, Ribavirin, Oseltamivir) versus Oseltamivir for the treatment of influenza in adults at risk for complications
This is a multicentered, randomized double-blind phase 2 study that will assess the efficacy, safety, and…
Towards a functional cure for HBV: exploiting lessons from HIV-HBV co-infection
This study willtest the hypothesis that HBsAg & HBeAg seroconversion/loss in HIV-HBV co-infected individuals following antiviral…
Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for drug-sensitive Tuberculosis (TRUNCATE-TB)
This is a two-month regimens using novel combinations to augment treatment effectiveness for drug-sensitive tuberculosis (TB):…
A phase 3b, randomized, open-label study of the antiviral activity and safety of Dolutegravir compared to Lopinavir/Ritonavir both administered with dual nucleoside reverse transcriptase inhibitor therapy in HIV-1 infected adult subjects with treatment failure on first line therapy
This study is conducted to demonstrate non-inferior antiviral activity at 48 weeks of a dolutegravir (DTG)…
